ICON (ICLR) Earnings Date & Reports

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ICLR is expected to report earnings to rise 3.45% to $3.30 per share on July 23

Q2'25

Est.

$3.30

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.50

Q2'24

Beat

by $0.08

The last earnings report on April 30 showed earnings per share of $3.19, beating the estimate of $3.18. With 71.44K shares outstanding, the current market capitalization sits at 27.35B.

View a ticker or compare two or three

Compare

ICLR